MedPath

180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma

Not Applicable
Completed
Conditions
Glaucoma, Open Angle, Pseudo-exfoliative
Glaucoma
Open Angle Glaucoma
Ocular Hypertension
Pigment Dispersion Syndrome
Interventions
Procedure: Selective Laser Trabeculoplasty
Registration Number
NCT02628223
Lead Sponsor
Temple University
Brief Summary

Selective laser trabeculoplasty (SLT) is a well-recognized way to lower eye pressure in treatment of glaucoma. This treatment is performed for 180 degrees or 360 degrees, and studies at academic centers have shown mixed results when comparing the success rates of 180 degrees or 360 degrees. Both protocols are now typically done by comprehensive ophthalmologists. However, there is no data that compares success rates of 180 degrees and 360 degrees in the community setting.

Detailed Description

This study is designed as a prospective evaluation of the two treatment algorithms for SLT by measuring intraocular pressure (IOP) after treatment. The hypothesis is that 360 degrees of SLT will produce a greater reduction in IOP than 180 degrees of SLT at 3 months follow up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
  • patients who have been diagnosed with open-angle glaucoma including ocular hypertension, pseudoexfoliation and pigment dispersion syndrome
  • greater than 18 years of age
  • initial intraocular pressure (IOP) of ≥ 21 mmHg
Exclusion Criteria
  • prior medical or laser therapy to lower IOP
  • previous incisional glaucoma surgery before the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
180 degreesSelective Laser Trabeculoplasty180 degrees of Selective Laser Trabeculoplasty using Neodymium:Yttrium Aluminum Garnet (YAG) laser
360 degreesSelective Laser Trabeculoplasty360 degrees of Selective Laser Trabeculoplasty using Neodymium:Yttrium Aluminum Garnet (YAG) laser
Primary Outcome Measures
NameTimeMethod
Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at Three Months of Follow-up3 months

Intraocular pressure (IOP) measured by tonometry in millimeters of mercury at three months of follow-up

Secondary Outcome Measures
NameTimeMethod
Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at 1 Year of Follow-up1 year

Intraocular pressure (IOP) measured by tonometry in millimeters of mercury at 1 year of follow-up

Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at Time at Which Additional Glaucoma Therapy is Requiredwithin 1 year of study intervention

Intraocular pressure (IOP) measured by tonometry in millimeters of mercury at time at which additional glaucoma therapy is required

Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at Last Follow-upwithin 1 year of study intervention

Intraocular pressure (IOP) measured by tonometry in millimeters of mercury at last follow-up

Trial Locations

Locations (2)

Brandywine Eye Center

🇺🇸

Wilmington, Delaware, United States

Levin Luminais Chronister Eye Associates

🇺🇸

Thorndale, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath